Jazz Pharma OKs new $400M in stock buybacks

|About: Jazz Pharmaceuticals, ... (JAZZ)|By:, SA News Editor

The board of Jazz Pharmaceuticals (NASDAQ:JAZZ) has authorized a $400M increase in its share repurchase program. Previously, it had approved $620M in buybacks, of which $194M has been purchased through September 30.

Subscribe for full text news in your inbox